Bliss GVS Pharma Ltd. (BLISSGVS)
NSE
Closed
Sep 3, 2026
Day's Range
635.0052 wk Range
118.00Overview - BLISSGVS - Bliss GVS Pharma Ltd.
Key Statistics
Valuation
Enterprise Value
71.85B
P/E (Trailing)
‪54.82‬
PEG Ratio
‪3.44‬
Price / Sales (TTM)
‪7.31‬
Price / Book
‪6.13‬
EV / EBITDA
‪37.39‬
Profitability
Gross Margin
‪59.92%‬
Profit Margin
‪13.54%‬
Operating Margin
‪23.27%‬
Return on Assets
‪8.65%‬
Return on Equity
‪10.48%‬
Ownership
Shares Outstanding
106.33M
Float
45.11M
Held by Insiders
‪57.44%‬
Held by Institutions
‪9.81%‬
Price stats
Beta
‪1.23‬
50-Day Avg
‪522.43‬
200-Day Avg
‪316.83‬
Dividends
Payout Ratio
‪7.93%‬
Frequency
Annual
Market Cap - BLISSGVS - Bliss GVS Pharma Ltd.
Peers - BLISSGVS - Bliss GVS Pharma Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NSE.
- BLISSGVSNSEBliss GVS Pharma Ltd.73.67BMarket Cap+78.08%52-week change54.83P/E (Trailing)‪13.54%‬Profit Margin
- DIVISLABNSEDivi's Laboratories Ltd.2.45TMarket Cap+34.05%52-week change95.31P/E (Trailing)‪26.04%‬Profit Margin
- CIPLANSECipla Ltd.1.14TMarket Cap-11.50%52-week change34.09P/E (Trailing)‪12.00%‬Profit Margin
- LAURUSLABSNSELaurus Labs Ltd.1.04TMarket Cap+55.80%52-week change95.68P/E (Trailing)‪15.04%‬Profit Margin
- LUPINNSELupin Ltd.992.95BMarket Cap+12.96%52-week change18.10P/E (Trailing)‪18.45%‬Profit Margin
- DRREDDYNSEDr. Reddy's Laboratories Ltd.981.26BMarket Cap-8.65%52-week change29.70P/E (Trailing)‪9.99%‬Profit Margin
- MANKINDNSEMankind Pharma Ltd.953.72BMarket Cap-15.82%52-week change46.78P/E (Trailing)‪13.85%‬Profit Margin
Profile Summary - BLISSGVS - Bliss GVS Pharma Ltd.
About
Bliss GVS Pharma Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and marketing of pharmaceutical products. The primary focus of the company is to offer affordable and effective healthcare solutions through its extensive range of products, which include anti-malarial,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
